BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30373440)

  • 21. Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid.
    Husain A; Blumenschein G; Esmaeli B
    Int J Dermatol; 2008 Mar; 47(3):276-9. PubMed ID: 18289332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Factors and Survival Outcome in Patients with Chordoma in the United States: A Population-Based Analysis.
    Lee IJ; Lee RJ; Fahim DK
    World Neurosurg; 2017 Aug; 104():346-355. PubMed ID: 28457925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noninvasive and curative radiation therapy for sebaceous carcinoma of the eyelid.
    Hata M; Koike I; Omura M; Maegawa J; Ogino I; Inoue T
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):605-11. PubMed ID: 21300468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mohs micrographic surgery versus wide local excision for sebaceous adenocarcinoma of the eyelid : Analysis of a national database.
    Phan K; Loya A
    J Plast Reconstr Aesthet Surg; 2019 Jun; 72(6):1007-1011. PubMed ID: 30894313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sebaceous carcinoma of the ocular region: a review.
    Shields JA; Demirci H; Marr BP; Eagle RC; Shields CL
    Surv Ophthalmol; 2005; 50(2):103-22. PubMed ID: 15749305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nordic treatment practices survey and consensus for treatment of eyelid sebaceous carcinoma.
    Leivo T; Sarmela J; Enckell-Aaltonen M; Dafgård Kopp E; Schmitt C; Toft PB; Sigurdsson H; Uusitalo M
    BMC Ophthalmol; 2020 Mar; 20(1):103. PubMed ID: 32178641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mohs micrographic surgery for eyelid sebaceous carcinoma: A multicenter cohort of 360 patients.
    Zhou C; Wu F; Chai P; Shi Y; Ye J; Shi X; Tan J; Ding Y; Luo Y; Esmaeli B; Jia R; Fan X
    J Am Acad Dermatol; 2019 Jun; 80(6):1608-1617.e1. PubMed ID: 30639290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved survival rates in sebaceous carcinoma of the eyelid.
    Muqit MM; Roberts F; Lee WR; Kemp E
    Eye (Lond); 2004 Jan; 18(1):49-53. PubMed ID: 14707966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical relevance of cyclooxygenase 2 and peroxisome proliferator-activated receptor γ in eyelid sebaceous gland carcinoma.
    Jayaraj P; Sen S; Bhattacharya T; Arora J; Yadav S; Chhoker V; Kumar A; Dhanaraj PS; Yadavilli KS; Verma M
    Histopathology; 2016 Aug; 69(2):268-75. PubMed ID: 26791964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eyelid sebaceous gland carcinoma, validation of AJCC 8th edition T staging- a retrospective study from North India.
    Sen S; Bhardwaj M; Jayaraj P; Bakhshi S; Pushker N; Kashyap S; Bajaj MS; Khandpur S
    Acta Ophthalmol; 2023 Feb; 101(1):49-56. PubMed ID: 35751173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiation therapy for primary carcinoma of the eyelid: tumor control and visual function.
    Hata M; Koike I; Maegawa J; Kaneko A; Odagiri K; Kasuya T; Minagawa Y; Kaizu H; Mukai Y; Inoue T
    Strahlenther Onkol; 2012 Dec; 188(12):1102-7. PubMed ID: 23104519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sebaceous carcinoma of the eyelid--two case reports].
    Zieliński T; Antoszewski B
    Klin Oczna; 2014; 116(2):127-9. PubMed ID: 25345292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conjunctival epithelial involvement by eyelid sebaceous carcinoma. The 2003 J. Howard Stokes lecture.
    Shields JA; Demirci H; Marr BP; Eagle RC; Stefanyszyn M; Shields CL
    Ophthalmic Plast Reconstr Surg; 2005 Mar; 21(2):92-6. PubMed ID: 15778660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sebaceous carcinoma of the eyelid: a review of 14 cases.
    Callahan EF; Appert DL; Roenigk RK; Bartley GB
    Dermatol Surg; 2004 Aug; 30(8):1164-8. PubMed ID: 15274713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kissing tumors of sebaceous carcinoma on the eyelids in collision with melanocytic nevus: A case report.
    Lin YC; Chen WC; Wu CS; Liao JB; Wei KC
    J Dermatol; 2016 Apr; 43(4):447-9. PubMed ID: 26661447
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinicopathological features of considerable reduction in androgen receptor expression in sebaceous gland carcinoma of the eyelid.
    Yunoki T; Miyakoshi A; Otsuka M; Hayashi A
    Int Ophthalmol; 2019 Aug; 39(8):1703-1708. PubMed ID: 30027448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Head & neck acinar cell carcinoma: a population-based study using the seer registry.
    Yibulayin F; Feng L; Wang M; Lu MM; Luo Y; Liu H; Yang ZC; Wushou A
    BMC Cancer; 2020 Jul; 20(1):631. PubMed ID: 32641007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eyelid abscess masking underlying sebaceous cell carcinoma.
    Bacorn C; Kim E; Lin LK
    Orbit; 2020 Jun; 39(3):212-216. PubMed ID: 31530211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contemporary update of overall prognosis and nomogram to predict individualized survival for Chinese patients with eyelid sebaceous carcinoma.
    Zhou C; Shi Y; Chai P; Wu F; Xia W; He X; Shi Y; Huang H; Jia R; Fan X
    EBioMedicine; 2018 Oct; 36():221-228. PubMed ID: 30236450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of fine needle aspiration cytology in diagnosis of eyelid sebaceous carcinoma.
    Maheshwari R; Maheshwari S; Shekde S
    Indian J Ophthalmol; 2007; 55(3):217-9. PubMed ID: 17456941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.